LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early-stage breast cancer at very low risk of metastasis von Deluche, Elise, Michiels, Stefan, Fric, Daniele, Perrin, Christophe, Bailleux, Caroline, Bachelot, Thomas, Ko Kivok Yun, Pascal, De Rauglaudre, Gaetan, Mouret-Reynier, Marie-Ange, Le Scodan, Romauld, Vaz-Luis, Ines, Lacroix-Triki, Magali, Guyonneau, Clara, Andre, Fabrice

Volltext